Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions

Eun Kyeung Song1, Youn-Jung Son, Terry A Lennie

  • 1College of Nursing,University of Kentucky, Lexington, USA.

Insights

High trait anger and homocysteine levels independently predict recurrent cardiac events after percutaneous coronary interventions. These factors combined shorten the time to adverse cardiac events, suggesting anger management may improve outcomes.

Area of Science:

  • Cardiology
  • Psychosomatic Medicine

Background:

  • Trait anger, hostility, and homocysteine are linked to recurrent cardiac events post-percutaneous coronary interventions.
  • The interplay between trait anger/hostility and homocysteine in predicting cardiac events remains unclear.

Purpose of the Study:

  • To investigate the relationships among trait anger, hostility, serum homocysteine, and recurrent cardiac events.
  • To determine if trait anger or hostility modifies the association between homocysteine and cardiac events.

Main Methods:

  • Prospective study of 135 patients undergoing percutaneous coronary interventions.
  • Trait anger and hostility assessed using validated scales; serum homocysteine measured.
  • Recurrent cardiac events tracked for 6 months; hierarchical Cox regression analysis performed.

Main Results:

  • Trait anger (HR=1.11) and homocysteine (HR=1.10) were independent predictors of recurrent cardiac events.
  • High trait anger and high homocysteine significantly shortened time to recurrent cardiac events (P=.01).

Conclusions:

  • Trait anger exerts a combined effect on the association between homocysteine and recurrent cardiac events.
  • Interventions targeting trait anger reduction may improve cardiac outcomes by influencing both anger and homocysteine levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...